Evidence map›Paper›PMID 29719329›Full record

ArticleUrology annals

Primary urethral carcinoma: A Surveillance, Epidemiology, and End Results data analysis identifying predictors of cancer-specific survival.

Ilija Aleksic, Soroush Rais-Bahrami, Michael Daugherty, Piyush K Agarwal, Srinivas Vourganti, Gennady Bratslavsky

Open access · goldAbstract read
In one paragraph

Article in Urology annals. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Morphologic spectrum of the epithelial tumors of the male and female urethra.Virchows Archiv : an international journal of pathology · 2023
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ilija AleksicDivision of Urology, Albany Medical Center, Albany, NY, USA.
Soroush Rais-BahramiDepartment of Urology, University of Alabama At Birmingham, Birmingham, AL, USA.
Michael DaughertyDepartment of Urology, Upstate Medical University, Syracuse, NY, USA.
Piyush K AgarwalCenter For Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Srinivas VourgantiDepartment of Urology, Upstate Medical University, Syracuse, NY, USA.
Gennady BratslavskyDepartment of Urology, Upstate Medical University, Syracuse, NY, USA.
Albany Medical Center Hospital · USSUNY Upstate Medical University · USInstitute of the North · US

Funding

Molecular Targeted Photoimmunotherapy for Bladder CancerZIABC011458 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI AGARWAL, PIYUSH · 2012 to 2019
$3.5M
6 · The paper itself

Abstract

objectivesPrimary urethral carcinoma (PUC) is rare, accounting for <1% of genitourinary malignancies. Current knowledge regarding is founded upon tertiary care centers reporting their experiences. We aim to identify factors predictive of outcomes using a nationwide registry database. MATERIALS AND

methodsThe Surveillance, Epidemiology, and End Results-18 registries database was queried for cases of PUC ranging between 2004 and 2010. To identify PUC cases, ICD-O site code C68.0 was used as a filter, hence identifying PUC with histologic subtypes including urothelial carcinoma (UC), squamous cell carcinoma (SCC), and adenocarcinoma (AC). Tumor characteristics were compared using log-rank analysis, and survival outcomes were compared using Cox proportional hazards models.

resultsA total of 419 PUC cases were identified, 250 (59.7%) male and 169 (40.3%) female patients. The most common histology in men was UC (134, 53.6%), followed by SCC (87, 34.8%) and AC (29, 11.6%). The most common histology in women was AC (79, 46.7%), followed by SCC (43, 25.4%) and UC (42, 24.9%). Log-rank analysis illustrated significant difference in cancer-specific survival (CSS) for T-stage, N-stage, M-stage, and stage of PUC with all histological variants combined (

conclusionsKnowledge of patient and tumor characteristics that influences survival is paramount in dictating management. The present study illustrates that age and stage are factors significantly associated with CSS in PUC.

Indexed as

and End ResultsEpidemiologyGender influenceSurveillancesurvivalurethral carcinoma

Identifiers

PMID29719329
PMCPMC5907326
OpenAlexW2790095264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.